Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platform (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.lanepe.2023.100741
Publication URI: http://dx.doi.org/10.1016/j.lanepe.2023.100741
Type: Journal Article/Review
Parent Publication: The Lancet Regional Health - Europe